Frontlight ResearchEarly access
Acute myeloid leukaemia trials in United States
302 of 334 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleThe Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Where
- Akron, Albany, Albuquerque, Allentown, Anchorage, Ann Arbor, Asheville, Atlanta, Aurora, Austin, Baltimore, Bangor, Bethesda, Birmingham, Boise, Boston, Brooklyn, Chapel Hill, Charleston, Charlotte, Charlottesville, Chicago, Cincinnati, Cleveland, Columbia, Columbus, Corpus Christi, Dallas, Danville, Dayton, Denver, Des Moines, Detroit, Downey, Durham, East Lansing, El Paso, Falls Church, Fargo, Fort Lauderdale, Fort Myers, Fort Worth, Gainesville, Grand Rapids, Greenville, Hackensack, Hartford, Hershey, Hollywood, Honolulu, Houston, Indianapolis, Iowa City, Jackson, Jacksonville, Kalamazoo, Kansas City, Knoxville, Las Vegas, Lebanon, Lexington, Little Rock, Loma Linda, Long Beach, Los Angeles, Louisville, Lubbock, Madera, Madison, Marshfield, Maywood, Memphis, Mesa, Miami, Mineola, Minneapolis, Mobile, Morgantown, Morristown, Nashville, Neptune City, New Brunswick, New Haven, New Hyde Park, New Orleans, New York, Norfolk, Oakland, Oak Lawn, Oklahoma City, Omaha, Orange, Orlando, Palo Alto, Park Ridge, Paterson, Pensacola, Peoria, Philadelphia, Phoenix, Pittsburgh, Portland, Providence, Reno, Richmond, Roanoke, Rochester, Royal Oak, Salt Lake City, San Antonio, San Diego, San Francisco, Savannah, Scarborough, Seattle, Sioux Falls, Spokane, Springfield, St Louis, Stony Brook, St. Petersburg, Syracuse, Tacoma, Tampa, The Bronx, Toledo, Tucson, Valhalla, Washington D.C., West Palm Beach, Wilmington, Winfield, Winston-Salem
- Age
- Up to 22 years
- People
- 960 worldwide
- Run by
- PedAL BCU, LLC
See details and how to joinNCT04726241 - Phase 1/2Taking peopleA Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)
- Where
- Buffalo, Chicago, Columbus, Duarte, Grand Rapids, Houston, Tampa
- Age
- 18 years and over
- People
- 154
- Run by
- Debiopharm International SA
See details and how to joinNCT06969430 - Phase 2Taking peopleComparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
- Where
- Albuquerque, Anaconda, Ashland, Augusta, Basking Ridge, Baton Rouge, Berkeley, Billings, Boiling Springs, Boise, Boston, Bozeman, Brighton, Brunswick, Buffalo, Canton, Charlotte, Chelsea, Chicago, Clinton Township, Coeur d'Alene, Commack, Coon Rapids, Crown Point, Danville, Deer River, DeKalb, Detroit, Duluth, Durham, Easley, Edina, Edmonds, Escanaba, Evanston, Fairway, Flint, Fruitland, Geneva, Glenview, Grayslake, Great Falls, Green Bay, Greenville, Greer, Harrison, Hibbing, Highland Park, Hines, Hollywood, Issaquah, Jackson, Kalispell, Kansas City, Knoxville, La Crosse, Lake Forest, Lebanon, Little Rock, Livingston, Livonia, Long Branch, Louisville, Madison, Maywood, Meridian, Miami, Middletown, Milwaukee, Minneapolis, Missoula, Montvale, Nampa, New Brunswick, New Lenox, New York, Novi, Oconto Falls, Oklahoma City, Orland Park, Pembroke Pines, Philadelphia, Pittsburgh, Pontiac, Portland, Post Falls, Providence, Richmond, Rochester, Saint Louis Park, Saint Paul, Salt Lake City, Sandpoint, Sandstone, San Francisco, San Mateo, Scarborough, Seattle, Seneca, Sheboygan, South Portland, Stevens Point, Stony Brook, Sturgeon Bay, Syracuse, Toms River, Tucson, Uniondale, Virginia, Warrenville, West Bloomfield, Weston, Westwood, Wilkes-Barre, Winston-Salem, Ypsilanti
- Age
- 18 years and over
- People
- 93 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06672146 - Phase 1Taking peopleCD70.CAR for AML and Other CD70+ Leukemias
- Where
- Houston
- Age
- Up to 75 years
- People
- 78
- Run by
- Baylor College of Medicine
See details and how to joinNCT06345027 - Phase 1Taking peopleSafety of MT-401-OTS in Patients With Relapsed AML or MDS
- Where
- Duarte, Kansas City, Tampa
- Age
- 65 years and over
- People
- 40
- Run by
- Marker Therapeutics, Inc.
See details and how to joinNCT06552416 - Phase 2Taking peopleOlutasidenib With Azacitidine Followed by Olutasidenib Maintenance for the Treatment of IDH1-mutated Acute Myeloid Leukemia in Patients With Prior Treatment With Venetoclax Plus a Hypomethylating Agent
- Where
- Los Angeles, Orange, Sacramento
- Age
- 18 years and over
- People
- 28
- Run by
- University of California, Davis
See details and how to joinNCT07304011 - Phase 2Taking peopleTretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
- Where
- Houston, Nassau Bay, Sugar Land, The Woodlands
- Age
- 10 years and over
- People
- 151
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT01409161 - Phase 2Taking peopleCladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia
- Where
- Houston
- Age
- 18 years to 65 years
- People
- 508
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT02115295 - Phase 1/2Taking peopleDecitabine/Cedazuridine and Venetoclax in Combination With Ivosidenib or Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
- Where
- Houston
- Age
- 18 years and over
- People
- 84
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04774393 - Phase 2Taking peopleVenetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
- Where
- ‘Aiea, Albany, Albuquerque, Allentown, Anaconda, Appleton, Ashland, Augusta, Basking Ridge, Baton Rouge, Berkeley, Bethesda, Billings, Birmingham, Boiling Springs, Boise, Boston, Bozeman, Brighton, Brunswick, Buffalo, Burlington, Caldwell, Canton, Chapel Hill, Charleston, Charlotte, Charlottesville, Chelsea, Chicago, City of Saint Peters, Cleveland, Clinton Township, Coeur d'Alene, Collierville, Columbus, Commack, Coon Rapids, Creve Coeur, Crown Point, Danville, Decatur, Deer River, DeKalb, Detroit, Dublin, Duluth, Durham, Easley, Edina, Edmonds, Effingham, Evanston, Fairway, Flint, Fremont, Fresno, Fruitland, Gainesville, Geneva, Glenview, Grayslake, Great Falls, Green Bay, Greenville, Greer, Grenada, Hershey, Hibbing, Highland Park, Hines, Honolulu, Houston, Indianapolis, Iowa City, Issaquah, Jackson, Kalispell, Kansas City, Knoxville, La Crosse, Lake Forest, Lake Success, Las Vegas, Lebanon, Lexington, Little Rock, Livingston, Livonia, Long Branch, Los Angeles, Louisville, Madison, Manhasset, Mattoon, Maywood, Memphis, Meridian, Miami, Middletown, Milwaukee, Minneapolis, Missoula, Modesto, Montvale, Nampa, New Albany, Newberg, New Brunswick, New Haven, New Lenox, New York, Novi, Oakland, Oconto Falls, O'Fallon, Oklahoma City, Ontario, Oregon City, Orland Park, Overland Park, Oxford, Paramus, Peabody, Philadelphia, Pittsburgh, Pontiac, Portland, Post Falls, Providence, Richmond, Ridgewood, Rochester, Roseville, Sacramento, Saint Louis Park, Saint Paul, Salt Lake City, Sandpoint, Sandstone, San Francisco, San Jose, San Leandro, San Mateo, San Rafael, Santa Clara, Santa Rosa, Scarborough, Seattle, Seneca, Sheboygan, Shiloh, Southhaven, South Portland, South San Francisco, Springfield, Stevens Point, St Louis, Stony Brook, Sturgeon Bay, Syracuse, Toms River, Topeka, Tucson, Urbana, Vallejo, Virginia, Walnut Creek, Warrenville, West Bloomfield, West Haven, Weston, West Reading, Westwood, Wilkes-Barre, Winston-Salem, Ypsilanti
- Age
- 18 years and over
- People
- 147 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06317649 - Phase 3Taking peopleStudies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
- Where
- Albuquerque, Ann Arbor, Aurora, Austin, Boston, Buffalo, Burlington, Chapel Hill, Charlottesville, Chicago, Clovis, Columbus, Dallas, Denver, Detroit, Durham, Eugene, Fairway, Gilbert, Hartford, Houston, Iowa City, La Jolla, Lexington, Los Angeles, Madison, Manassas, Memphis, Miami, Milwaukee, Minneapolis, Nashville, New Brunswick, New Haven, New York, Orange, Philadelphia, Saint Paul, San Antonio, Tampa, Wheeling, Worcester
- Age
- 18 years and over
- People
- 1,300 worldwide
- Run by
- Kura Oncology, Inc.
See details and how to joinNCT07007312 · EU 2025-521314-25-00 - Phase 1Taking peoplePhase I Study Of PLM-102 In Patients With Relapsed And Refractory Acute Myeloid Leukemia
- Where
- Houston
- Age
- 18 years and over
- People
- 12
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07549464 - Phase 1Taking peopleATRN-119 in Combination With Decitabine in Patients With TP53-Mutated AML or Higher-Risk MDS
- Where
- St Louis
- Age
- 18 years and over
- People
- 36
- Run by
- Washington University School of Medicine
See details and how to joinNCT07617363 - Phase 1Taking peopleArsenic Trioxide to Prevent Relapse in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Where
- Ann Arbor
- Age
- 21 years and over
- People
- 20
- Run by
- University of Michigan Rogel Cancer Center
See details and how to joinNCT07737769 - Phase 1Taking peopleAllogeneic iNKT Cell Therapy (agenT-797) After SCT
- Where
- Madison
- Age
- 18 years and over
- People
- 22
- Run by
- University of Wisconsin, Madison
See details and how to joinNCT07758218 - Phase 2Taking peopleBlinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia
- Where
- Houston
- Age
- 18 years and over
- People
- 90
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03263572 - Phase 2Taking peopleDexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers
- Where
- Houston
- Age
- 12 years and over
- People
- 100
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03589729 - Phase 1/2Taking peopleThe Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
- Where
- Bethesda, Duarte
- Age
- 12 years to 120 years
- People
- 260
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05436418 - No phaseTaking peopleWhole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS
- Where
- St Louis
- Age
- 18 years and over
- People
- 375
- Run by
- Washington University School of Medicine
See details and how to joinNCT04986657 - Phase 2Taking peopleTesting New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
- Where
- ‘Aiea, Albany, Albuquerque, Allentown, Anaconda, Ann Arbor, Appleton, Ashland, Augusta, Baltimore, Basking Ridge, Baton Rouge, Bellevue, Berkeley, Bethesda, Billings, Birmingham, Bloomington, Boiling Springs, Boise, Boston, Bozeman, Brighton, Buffalo, Burlington, Caldwell, Camden, Canton, Carthage, Charleston, Charlotte, Charlottesville, Chelsea, Chicago, City of Saint Peters, Cleveland, Clinton Township, Coeur d'Alene, Collierville, Columbus, Commack, Coon Rapids, Creve Coeur, Crown Point, Danville, Decatur, Deer River, Detroit, Dixon, Duluth, Durham, Easley, Edina, Edmonds, Effingham, Eureka, Evanston, Fairfax, Fairway, Falls Church, Farmington Hills, Flint, Fruitland, Galesburg, Glenview, Great Falls, Green Bay, Greenville, Greer, Grenada, Harrison, Hershey, Hibbing, Highland Park, Honolulu, Indianapolis, Iowa City, Issaquah, Jackson, Jacksonville, Kalispell, Kansas City, Kewanee, Knoxville, La Crosse, Lake Success, Las Vegas, Lewistown, Lexington, Little Rock, Livingston, Livonia, Long Branch, Los Angeles, Louisville, Macomb, Madison, Manhasset, Maywood, Memphis, Meridian, Miami, Middletown, Milwaukee, Minneapolis, Missoula, Montvale, Nampa, New Albany, New Brunswick, New Haven, New Lenox, New York, Novi, Oakland, O'Fallon, Oklahoma City, Omaha, Ontario, Orland Park, Ottawa, Overland Park, Oxford, Paramus, Peabody, Pekin, Pembroke Pines, Peoria, Peru, Philadelphia, Phoenix, Pittsburgh, Pontiac, Portland, Post Falls, Princeton, Providence, Ridgewood, Rochester, Roseville, Sacramento, Saint Louis Park, Saint Paul, Salt Lake City, Sandpoint, Sandstone, San Francisco, San Mateo, Santa Clara, Scarborough, Seattle, Seneca, Southhaven, South Portland, Springfield, Stevens Point, St Louis, Stony Brook, Syracuse, The Bronx, Toms River, Tucson, Uniondale, Virginia, Washington, West Bloomfield, Weston, West Reading, Westwood, Wilkes-Barre, Winston-Salem, Ypsilanti
- Age
- 18 years to 59 years
- People
- 335 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05554406 - Phase 1Taking peopleCD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia
- Where
- Duarte
- Age
- 18 years and over
- People
- 27
- Run by
- City of Hope Medical Center
See details and how to joinNCT05672147 - Phase 2Taking peopleZiftomenib for the Treatment of Patients With NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia Not Eligible for Standard Therapy
- Where
- Columbus
- Age
- 18 years and over
- People
- 70
- Run by
- Uma Borate
See details and how to joinNCT06930352 - Phase 1Taking peopleEmapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
- Where
- Duarte
- Age
- 18 years to 75 years
- People
- 15
- Run by
- City of Hope Medical Center
See details and how to joinNCT06996119 - Phase 1Taking peopleA Study of CRD3874-SI in People With Leukemia
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Rockville Centre
- Age
- 18 years and over
- People
- 24
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07661095 - Phase 1/2Taking peopleVenetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms
- Where
- Seattle
- Age
- 18 years and over
- People
- 62
- Run by
- University of Washington
See details and how to joinNCT04797767